Sanofi Forms Standalone Consumer Healthcare Unit: Prelude To Spin-Off?

Sanofi Consumer Healthcare is to operate as a standalone unit in a move which is being viewed as a prelude to a potential spin-off. High profile prescription-to-OTC switches are a priority for the revamped business. 

Sanofi plans to operate its Consumer Healthcare unit as a standalone business in a move which is being viewed as a prelude to a potential spin-off.

The French pharma giant’s CEO Paul Hudson – who took the reins in September – outlined his ambition to shake-up Consumer Healthcare before revealing more detailed strategic plans during Sanofi’s Capital Markets Day

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

More from Business